Samrat Pharmachem

quarterly
yearly
ParticularsJun '23Sep '23Dec '23Mar '24Jun '24
Revenue57.8480.0462.0982.9881.41
Expenses57.0979.8161.9581.6078.59
EBITDA1.130.530.531.653.17
EBIT0.970.370.371.503.01
Profit Before Tax0.750.240.141.392.82
Net Profit0.61-0.190.341.402.07
Financial Ratios
Operating Profit Margin1.97%0.66%0.86%2.00%3.92%
Net Profit Margin1.06%-0.24%0.55%1.69%2.56%
Earning Per Share (Diluted)1.98-0.611.114.526.68
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ